ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Narhex Life Sciences Limited
Industry Group: Biotechnology / Medical Research - Pharmaceuticals - Generic & Specialty

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Narhex Life Sciences Limited is an Australian-based company. The Company is principally engaged in the development, manufacturing and marketing of human immunodeficiency virus (HIV) related diagnostics and therapeutic products and the development of the Company’s intellectual Property. The company develops and commercializes its anti-HIV protease inhibitor DG-17. The DG-17 is the water-soluble pro drug of the active anti-HIV drug DG-35. Narhex Life Sciences Limited operates in three main geographical areas: Australasia, Sweden and China.

Financial Summary
BRIEF: For the Six months ended 31 December 2011, Narhex Life Sciences Limited's revenues increased from A$0 to A$36K. Net loss from continuing operations increased 19% to A$275K. Revenues reflects an increased in income from operation. Higher net loss reflects an increase in administrative expenses and the presence of employee benefit expenses. The Company is engaged in drug manufacturing like HIV protease inhibitor and therapeutic.

Business Address


C/- K R Corporate Compliance Pty Ltd
MELBOURNE, VIC 6000
Phone: 61-3-96055917
Fax: 61-3-96055928
http://www.narhex.com/

ASX Share Price Information
Current Price 0.010
Current Price Date 04/05/2012
52 Week Hi/Low 0.04 - 0.01
Avg Volume Last ten Days 0.00
ASX Company Sizing
Market Cap 4.30
Revenues 2.66
EBITDA -0.40
Net Income -0.53
Number of Employees 3
Enterprise Value 2.66
Research Analyst Forecast
Consensus Recommendation -
Target Price -
LT Growth Rate -
Projected P/E -
Sales -
EPS -
Profit -
DPS -
Share Ratios
EPS -0.00224
RPS 0.00035
BV per Share 0.00403
Cash per Share 0.00381
Cashflow per Share -
Cashflow per Share 0.00000
Financial Ratios
Gross Margin 100.00000
ROE -77.85244
Price/Sales 52.13544
P/E -
P/Book 2.48026